Buoyed by Insiders, Flagship’s Evelo Hits Midpoint of IPO Range
Published on
Evelo Biosciences, a biotech company based on technology licensed through the Polsky Center from UChicago Medicine’s Thomas Gajewski, debuted on Nasdaq.